Kula Investments, LLC Pacira Bio Sciences, Inc. Transaction History
Kula Investments, LLC
- $405 Billion
- Q1 2023
A detailed history of Kula Investments, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Kula Investments, LLC holds 31,665 shares of PCRX stock, worth $644,699. This represents 0.32% of its overall portfolio holdings.
Number of Shares
31,665Holding current value
$644,699% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
294Shares Held
48.6MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$161 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$104 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$39 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$38.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$38.3 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $933M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...